| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/06/2008 | EP1432714B1 Chemical compounds |
| 08/06/2008 | EP1385518B1 Benzimidazolone compounds |
| 08/06/2008 | CN101238131A Bridged piperazine and piperidine derivatives as CCR1 antagonists |
| 08/06/2008 | CN101238130A Preparation of a 7H-pyrrolo[2,3-D]pyrimidine derivative |
| 08/06/2008 | CN101238129A Compounds that maintain pluripotency of embryonic stem cells |
| 08/06/2008 | CN101238128A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 08/06/2008 | CN101238127A Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| 08/06/2008 | CN101238126A Pyrrolobenzodiazepines and heteroaryl, aryl and cycloalkylamino ketone derivatives as follicle stimulating hormone receptor -(FSH-R) antagonists |
| 08/06/2008 | CN101235037A Method for synthesizing alkoxyporphyrin |
| 08/06/2008 | CN101235036A Porphyrin derivative and application for the same as small molecule antioxidant |
| 08/06/2008 | CN101235035A Method for preparing tetramethoxymethylglycoluril |
| 08/06/2008 | CN100408643C Use of marine fungus originated compounds as antifouling agents |
| 08/06/2008 | CN100408581C 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408564C Pyrazole derivatives for treating HIV |
| 08/06/2008 | CN100408038C Use of a vitamin combination for the treatment of primary headaches |
| 08/05/2008 | US7408065 P2X7 receptor antagonists and their use |
| 08/05/2008 | US7408063 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 08/05/2008 | US7408061 Rylene dyes |
| 08/05/2008 | US7408058 Regioisomerically pure oxochlorins and methods of synthesis |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407971 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407962 Heteroaryl compounds useful as inhibitors or protein kinases |
| 08/05/2008 | US7407952 substance P, integrin receptor antagonist; mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; antiinflammatory agent; cell adhesion-mediated disease and central nervous system disorders |
| 08/05/2008 | US7407951 Pyrrolobenzodiazepines |
| 08/05/2008 | US7407949 4-(2-Cyclopropyl-ethyl)-piperazine-1-carboxylic acid 2-methyl-4-(3-methyl-4,10-dihydro-3H-2,3,4,9-tetraaza-benzo[f]azulene-9-carbonyl)-benzylamide; inter alia, primary dysmenorrhoea, male erectile dysfunction |
| 08/05/2008 | US7407938 1,4-Diphenyl-3-(3-hydroxy-3-phenylpropyl)-2-azetidinones, e.g., 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-y]lbenzylcarbamoyl}phenoxy)benzoic acid; antilipemic agents that have intestinal absorption of less than 10%, |
| 08/05/2008 | CA2388476C Bicyclic imidazo-5-yl-amine derivatives |
| 08/05/2008 | CA2224435C Pyrrolopyrimidines and processes for the preparation thereof |
| 07/31/2008 | WO2008090379A1 Pyrazoloquinazolinones as inhibitors of poly(adp-ribose)polymerase (parp) |
| 07/31/2008 | WO2008073687A3 Compounds and compositions as protein kinase inhibitors |
| 07/31/2008 | WO2008065444A3 Substituted quinazolines |
| 07/31/2008 | WO2008063232A3 Substituted pyrazolopyrimidines |
| 07/31/2008 | WO2008045267A3 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 07/31/2008 | WO2008011557A3 Heteroaryl inhibitors of rho kinase |
| 07/31/2008 | WO2008005456A3 Fused heterocyclic inhibitors of d-amino acid oxidase |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/31/2008 | US20080182861 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 07/31/2008 | US20080182849 Certain Heterocyclic Substituted Imidazo[1,2-A]Pyrazin-8-Ylamines And Methods Of Inhibition Of Bruton's Tyrosine Kinase By Such Compounds |
| 07/31/2008 | US20080182848 anxiety; insomnia; high yielding; optically resolving eszopiclone using a multi-column continuous process or a simulated moving bed process; stationary phase used in chiral chromatography process is a derivative of tris(3,5-dimethylphenyl carbamate), or a derivative of tris- alpha -methylbenzylcarbamate |
| 07/31/2008 | US20080182834 less toxic than the unassociated metal complex by hindering reactions in the blood stream; antitumor agents; platinum, palladium, gold amine inclusion compounds |
| 07/31/2008 | US20080182302 Open reading frames which encode polypeptides sufficient to direct the biosynthesis synthesis of a safracin molecule having improved properties and that could be used in the hemi-synthesis of new ecteinascidins compounds; combinatorial chemistry; antitumor agents; broad-spectrum antibiotics; bactericides |
| 07/30/2008 | EP1950213A2 Process for the synthesis of N-[3- (3-cyanopyrazolo [1,5a] pyrimidin-7-yl) -phnyl] -N-ethyl-acetamide |
| 07/30/2008 | EP1950212A1 Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1948664A2 Pyrrolotriazine kinase inhibitors |
| 07/30/2008 | EP1948663A2 Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators |
| 07/30/2008 | EP1948662A2 Tricyclic compounds useful as oxytocin receptor agonists |
| 07/30/2008 | EP1948661A1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 07/30/2008 | EP1948660A1 Tetracyclic indole derivatives as antiviral agents |
| 07/30/2008 | EP1948659A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 07/30/2008 | EP1948658A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 07/30/2008 | EP1948656A2 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/30/2008 | EP1948601A1 Fab i inhibitor and process for preparing same |
| 07/30/2008 | EP1948242A2 Duocarmycin derivatives as novel cytotoxic compounds and conjugates |
| 07/30/2008 | EP1948162A1 Pharmaceutical compositions containing erythrine mulungu derivatives and processes for their production |
| 07/30/2008 | EP1725558A4 Method for preparing compounds comprising cucurbituril groups |
| 07/30/2008 | EP1716152B1 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders |
| 07/30/2008 | EP1603918B1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 07/30/2008 | EP1592684B1 Malonamide derivatives as gamma-secretase inhibitors |
| 07/30/2008 | CN101233138A Pyrrolo[2,3-d]pyrimidine derivatives, their intermediates and synthesis |
| 07/30/2008 | CN101233137A Macrocylic inhibitors of hepatitis c virus |
| 07/30/2008 | CN101233136A Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
| 07/30/2008 | CN101233135A Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV |
| 07/30/2008 | CN101233134A 制备泛昔洛韦和其它嘌呤衍生物 Preparation of famciclovir and other purine derivatives |
| 07/30/2008 | CN101232885A Substituted pyridazinyl- and pyrimidinyl-quinolin-4-ylamine analogues |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN101229164A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 07/30/2008 | CN100406466C Nucleic acid hydrolysis cutting agent based on cucurbituril |
| 07/30/2008 | CN100406459C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406010C Antitumor agents and process for producing the same |
| 07/29/2008 | US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 07/29/2008 | US7405300 Central nervous system disorders; cardiovascular disorders; antiischemic agents; strokes; antiarthritic agents; anticancer agents; muscular disorders |
| 07/29/2008 | US7405299 Compounds as pharmaceutical agents |
| 07/29/2008 | US7405298 Process for making risperidone and intermediates therefor |
| 07/29/2008 | US7405297 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
| 07/29/2008 | US7405295 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| 07/29/2008 | US7405221 2-(4-fluorobenzyloxy)-4-(2,4-dichlorophenyl)-5-(4-chlorophenyl)pyrimidine; antagonists or inverse agonists of the Cannabinoid-1 (CB1) receptor; antidepressant, neuroleptic, anxiolytic, antiinflammatory agent, cognition activator; psychosis, epilepsy, Parkinson's disease, and schizophrenia |
| 07/29/2008 | US7405220 Pyrazolopyrimidines |
| 07/29/2008 | US7405219 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 07/29/2008 | US7405218 Isothiazole derivatives useful as anticancer agents |
| 07/29/2008 | US7405213 such as 3-chloro-4-fluoro-N-(5-{[6-({3-[4-(hydroxymethyl)piperidin-1-yl]propyl}oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino}pyrimidin-2-yl)benzamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent |
| 07/29/2008 | US7405212 Helix mimetics and composition and methods related thereto |
| 07/29/2008 | US7405041 Methods for regulating transcription by targeting quadruplex DNA |
| 07/29/2008 | CA2515596C Cannabinoid receptor ligands and uses thereof |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 07/29/2008 | CA2254070C Method for treating viral infections |
| 07/29/2008 | CA2214086C Pyrazole derivatives and processes for the preparation thereof |
| 07/24/2008 | WO2008089390A1 New classical antifolates |
| 07/24/2008 | WO2008089027A1 Compounds for the treatment of hepatitis c |
| 07/24/2008 | WO2008087936A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes |
| 07/24/2008 | WO2008087529A1 Nicotinic acetylcholine receptor modulators |
| 07/24/2008 | WO2008087278A2 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors |
| 07/24/2008 | WO2008068424A3 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 07/24/2008 | WO2008068272A3 Antibacterial quinoline derivatives |
| 07/24/2008 | WO2008051808A3 Bicyclic triazoles as protein kinase modulators |